News from GBI Research A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 14, 2016, 10:11 ET Cancer Immunotherapies Market to Grow by Over $58 Billion by 2022 as Innovation Thrives, Says GBI Research

A new report from business intelligence provider GBI Research - Global Cancer Immunotherapies Market to 2022 - states that the market size for...


Dec 08, 2016, 11:00 ET Big Data is Already Providing Commercial Benefits to Pharma Companies, Says GBI Research

Big Data simply refers to any data set which is too large to store, process or analyze using traditional database software and hardware. As...


Dec 01, 2016, 11:00 ET Alzheimer's Patients may Benefit Significantly From an Array of Diabetes Treatments, Says GBI Research

A new Analyst View from business intelligence provider GBI Research - Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease - states...


Nov 29, 2016, 11:25 ET Asia-Pacific Anti-hypertensive Therapeutics Market will Increase by Almost $8 Billion by 2022, says GBI Research

A new report from business intelligence provider GBI Research - Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - states that the...


Nov 28, 2016, 09:00 ET Unmet Needs in Type 2 Diabetes Mellitus Market Leave Ample Opportunity for Investment, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Type 2 Diabetes Mellitus - states that the increasing demand for...


Nov 23, 2016, 10:00 ET Healthcare Sector Faces Significant Investment Barriers due to Pricing Pressures and Declining R&D Productivity, Says GBI Research

A new report from business intelligence provider GBI Research - Strategic Trends in Private Equity and Venture Capital Funding for Healthcare -...


Nov 22, 2016, 09:00 ET Asthma Treatment's Significant Unmet Needs May be Addressed By Calcilytics, Says GBI Research

A new whitepaper from business intelligence provider GBI Research - An Exploration of Novel and Repositioned Calcium Transport Mediators as...


Nov 21, 2016, 10:00 ET Uro-oncology Space set for Transformation by Pipeline Immune Checkpoint Inhibitors, Says GBI Research

A new Analyst View from business intelligence provider GBI Research - Urological Cancer Treatment Landscape to be Transformed by the Approval of...


Nov 17, 2016, 09:00 ET Cancer Vaccines Market Will Record Impressive Growth of Around $5 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Global Cancer Vaccines Market to 2022 - states that the cancer vaccines market is...


Nov 16, 2016, 10:00 ET Private Equity and Venture Capital Funding Crucial for Healthcare Innovation, says GBI Research

Private equity (PE) and venture capital (VC) funds have been important participants in a wide range of industries for many decades - particularly...


Nov 14, 2016, 11:00 ET Pharmaceutical Companies Turn Attention Towards Synthetic Cannabinoids as Evidence of Their Therapeutic Properties Strengthens, Says GBI Research

A new whitepaper from business intelligence provider GBI Research - The Emerging Field of Cannabinoid-Based Products - states that despite legal...


Nov 09, 2016, 11:00 ET Increased Development of Highly-targeted Biologics Set to Change Composition of Asthma Therapeutics Market, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Asthma Therapeutics - states that the asthma therapeutics market...


Jul 21, 2016, 09:01 ET Stem Cell Therapies Facing Commercial Challenges Despite Promising Pipeline, Says GBI Research

A new report from business intelligence provider GBI Research - Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D...


Jul 19, 2016, 07:00 ET APAC Osteoporosis Market Will Rise From $4.5 Billion in 2015 to $7.7 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Osteoporosis Therapeutics in Asia -Pacific Markets to 2022 - states that the...


Jun 30, 2016, 07:00 ET Urological Cancers Market Set to Approach $36 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Global Urological Cancer Market to 2022 - states that the urological cancers...


Jun 28, 2016, 09:00 ET Diabetes Complications Pipeline Has High Potential for Change as 30% of Products Considered First-in-Class, says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Diabetic Complications - states that the diabetes complications...


Jun 21, 2016, 11:00 ET Hematological Cancers Space Abounds with Innovation, Most Notably in the Leukemia Segment, Says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Hematological Cancers - states that of the three major...


Jun 16, 2016, 09:00 ET First-in-class Products Show Way Forward for Pharmaceutical Industry, Says GBI Research

A new report from business intelligence provider GBI Research - Innovation Tracking Factbook 2016 - states that, with the cost of bringing a...


May 05, 2016, 11:00 ET Asia-Pacific Non-Small Cell Lung Cancer Market to Reach Almost $5 Billion by 2022, says GBI Research

A new report from business intelligence provider GBI Research - Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - states...


May 03, 2016, 11:00 ET Global Dermatology Market Hit $20 Billion in 2015 and Will Reach $33.7 Billion by 2022, Says GBI Research

A new report from business intelligence provider GBI Research - Global Dermatology Market to 2022 - states that the global dermatology market is...


Apr 28, 2016, 08:00 ET Hematological Cancers Market to Hit $70.1 Billion by 2022 Despite Key Patent Expirations, Says GBI Research

A new report from business intelligence provider GBI Research - Global Hematological Cancers Market to 2022 - states that the market for...


Mar 29, 2016, 11:00 ET Substance Abuse Treatment Pipeline Dominated by Nicotine and Alcohol Addiction Treatments, Says GBI Research

A new report from business intelligence provider GBI Research - Substance Abuse Deterrents and Treatments: An Assessment of the Technological,...


Mar 22, 2016, 09:00 ET Asia-Pacific Alzheimer's Disease Market to Hit $5.1 Billion by 2021, says GBI Research

A new report from business intelligence provider GBI Research - Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - states that the...


Mar 17, 2016, 08:00 ET Monoclonal Antibodies Headline Innovation in Gastric Cancer Treatment Pipeline, says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Gastric Cancer -states that while 99% of currently marketed...


Mar 08, 2016, 10:00 ET Asia-Pacific Asthma Market Hit $3.5 Billion in 2014 and Will Reach $5.6 Billion by 2021, Says GBI Research

A new report from business intelligence provider GBI Research - Asthma Therapeutics in Asia-Pacific Markets to 2021 - states that the asthma...